Normal tissue tolerance to external beam radiation therapy: Spinal cord;Tolérance à l'irradiation des tissus sains: moelle épinière

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 269-276

  Habrand, J L ^a,b   Drouet, F ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Radiation myelopathy; Spinal cord

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTARABINE; CYTOKINE; DACTINOMYCIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CERVICAL SPINE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LUMBAR SPINE; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SHORT SURVEY; SPINAL CORD; SPINAL CORD DISEASE; SURGICAL TECHNIQUE; THORACIC SPINE;

ABNORMALITIES, RADIATION-INDUCED; CONTRAST MEDIA; DOSE FRACTIONATION; HALF-LIFE; HUMANS; NERVOUS SYSTEM DISEASES; NEUROGLIA; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SPINAL CORD; SPINAL CORD DISEASES;

EID: 77955337807     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.03.004     Document Type: Short Survey

References (65)

1. Abbatucci J.S., Delozier T., Quint R., Rousel A., Brune D. Radiation myelopathy of the cervical spinal cord: time, dose, and volume factors. Int J Radiat Oncol Biol Phys 1978, 4:239-248.
2. Al-Jahdari W.S., Suzuki Y., Yoshida Y., Hamada N., Shirai K., Noda S.E., et al. The radiobiological effectiveness of carbon-ion beams on growing neurons. Int J Radiat Biol 2009, 85:700-709.
3. Anderson P.R., Coia L.R. Fractionation and outcomes with palliative radiation therapy. Semin Radiat Oncol 2000, 10:191-199.
4. Ang K.K., van der Kogel A.J., Van Dam J., van der Schueren E. The kinetics of repair of sublethal damage in the rat cervical spinal cord during fractionated irradiations. Radiother Oncol 1984, 1:247-253.
5. Ang K.K., van der Kogel A.J., van der Schueren E. Lack of evidence for increased tolerance of rat spinal cord with decreasing fraction doses below 2 Gy. Int J Radiat Oncol Biol Phys 1985, 11:105-110.
6. Antunes N.L., Wolden S., Souweidane M.M., Lis E., Rosenblum M., Steinherz P.G. Radiation myelitis in a 5-year old girl. J Child Neurol 2002, 17:217-219.
7. Barstis J.L., Black A.C. Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine. Cancer Invest 2005, 23:596-598.
8. Bijl H.P., Van Luijk P., Coppes R.P., Schippers J.M., Konings A.W., van der Kogel A.J. Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord. Int J Radiat Oncol Biol Phys 2006, 64:1204-1210.
9. Blakemore W.F., Chari D.M., Gilson J.M., Crang A.J. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia. 2002, 38:155-168.
10. Bloss J.D., DiSaia P.J., Mannel R.S., Hyden E.C., Manetta A., Walker J.L., et al. Radiation myelitis: a complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of uterine cervix. Gynecol Oncol 1991, 43:305-308.
11. Breteau N., Wachter T., Kerdraon R., Guzzo M., Armaroli L., Chevalier D., et al. Utilisation des neutrons rapides dans le traitement des tumeurs des glandes salivaires: rationnel, revue de la littérature et expérience d'Orléans. Cancer Radiother 2000, 4:181-191.
12. Chamroonrat W., Posteraro A., El-Haddad G., Zhuang H., Alavi A. Radiation myelopathy visualized as increased FDG uptake on positron emission tomography. Clin Nucl Med 2005, 30:560.
13. Chi D., Béhin A., Delattre J. Neurologic complications of radiation therapy. Neurologic complications of cancer and its treatment 2008, Humana Press, pp. 259-86. 2nd ed.
14. Choi N.C.H., Grillo H.C., Gardiello M., Scannell H.G., Wilkins E.W. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1980, 6:31-35.
15. Chow E., Harris K., Fan G., Tsao M., Sze W.M. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007, 25:1423-1436.
16. Coderre J.A., Morris G.M., Micca P.L., Hopewell J.W., Verhagen I., Kleiboer B.J., et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res 2006, 166:495-503.
17. Cohen L., Ten Haken R.K., Mansell J., Yalavarthi S.D., Hendrickson F.R., Awschalom M. Tolerance of the human spinal cord to high energy p(66) Be(49) neutrons. Int J Radiat Oncol Biol Phys 1985, 11:743-749.
18. Debus J., Scholz M., Haberer T., Peschke P., Jäkel O., Karger C.P., et al. Radiation tolerance of the rat spinal cord after single and split doses of photons and carbon ions. Radiat Res 2003, 160:536-542.
19. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
20. Fowler J.F., Bentzen S.M., Bond S.J., Ang K.K., van der Kogel A.J., van den Bogaert W., et al. Clinical radiation doses for spinal cord: the 1998 international questionnaire. Radiother Oncol 2000, 55:295-300.
21. Gibbs I.C., Patil C., Gertszen P.C., Adler J.R., Burton S.A. Delayed radiation induced myelopathy after spinal radiosurgery. Neurosurgery 2009, 64:A67-72.
22. Goldwein J.W. Radiation myelopathy: a review. Med Ped Oncol 1987, 15:89-95.
23. Grosu A.-L., Andratschke N., Nieder C., Molls M. Retreatment of the spinal cord with palliative radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52:1288-1292.
24. Société française de radiothérapie oncologique (SFRO). Guide des procédures de radiothérapie externe. Cancer Radiother 2008;12:141-314.
25. Guthrie R.T., Ptacek J.J., Hjass A.C. Comparative analysis of two regimens of split course radiation in carcinoma of the lung. Am J Roentgenol 1973, 117:605-608.
26. Hopewell J., Withers H.R. Proposition: long-term changes in irradiated tissues are due principally to vascular damage in the tissues (point/counterpoint). Med Phys 1998, 25:2265-2268.
27. Jeremic B., Shibamoto Y., Igrutinovic I. Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck. J Cancer Res Clin Oncol 2001, 127:687-691.
28. Joiner M., Bentzen S.M., Time-Dose relationships: the linear-quadratic approach. In: Basic clinical radiobiology. 3rd ed. New York: A Hodder Arnold, pp. 120-33.
29. Lengyel Z., Réko G., Majtényi K., Pisch J., Csornai M., leszynyak J., et al. Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy. Spinal Cord 2003, 41:577-585.
30. Macbeth F.R., Wheldon T.E., Girling D.J., Stephens R.J., Machin D., Bleehen N.M., et al. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party. Clin Oncol 1996, 8:176-181.
31. Marucci L., Niemierko A., Liebsch N.J., Aboubaker F., Liu M.C.C., Munzenrider J.E. Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Int J Radiat Oncol Biol Phys 2004, 59:551-555.
32. Murakami H., Kawahara N., Yahata T., Yokoyamaka K., Komai K., Tomita K. Radiation myelopathy after radioactive iodine therapy for spine metastasis. Br J Radiol 2006, 79:e45-e49.
33. Nieder C., Ataman F., Price R.E., Kian Ang K. Radiation myelopathy: new perspectives on an old problem. Radiat Oncol Invest 1999, 7:193-203.
34. Nieder C., Grosu A.L., Andratschke N.H., Molls M. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys 2005, 61:851-855.
35. Niewald M., Feldmann U., Feiden W., Niedermayer I., Kiessling M., Lehmann W., et al. Multivariate logistic analysis of dose-effect relationship and latency of radiomyelopathy after hyperfractionated and conventionally fractionated radiotherapy in animal experiments. Int J Radiat Oncol Biol Phys 1998, 41:681-688.
36. Okada S., Okeda R. Pathology of radiation myelopathy. Neuropathology 2001, 21:247-265.
37. Pallis C.A., Louis S., Morgan R.L. Radiation myelopathy. Brain 1961, 84:460-479.
38. Philippens M.E.P., Pop L.A.M., Visser A.G., Schellekens S.A.M.W., van der Kogel A.J. Dose-volume effects in rat thoracolumbar spinal cord: an evaluation of NTCP models. Int J Radiat Oncol Biol Phys 2004, 60:578-590.
39. Rades D., Stalpers L.J.A., Hulshof M.C.C.M., Zschenker O., Alberti W., Koning C.C.E. Effectiveness and toxicity of single-fraction radiotherapy with 1 × 8 Gy for metastatic spinal cord compression. Radiother Oncol 2005, 75:70-73.
40. Rades D., Stalpers L.J.A., Veninga T., Schulte R., Hoskin P.J., Obralic N., et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005, 23:3366-3375.
41. Rampling R., Symonds P. Radiation myelopathy. Curr Opin Neurol 1998, 11:627-632.
42. Raney B., Tefft M., Heyn R., Newton W., Jones P.M., Haeberlen V., et al. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma. Cancer 1992, 15:1498-1506.
43. Reagan T.J., Thomas J.E., Colby M.Y. Chronic progressive radiation myelopathy Its clinical aspects and differential diagnosis. JAMA 1968, 203:106-110.
44. Reinhold H.S., van Putten W.L.J., Hopewell J.W., van der Kogel A.J. The latent period in clinical radiation myelopathy. Int J Radiat Oncol Biol Phys 1984, 10:2385-2387.
45. Ricard D., Psimaras D., Guillevin R., Hoang-Xuan K. Complications neurologiques de la radiothérapie, EMC (Elsevier Massons SAS, Paris). Neurologie 2008, 17-161-A10.
46. Rouvière H., Delmas A., Delmas V. Anatomie humaine: descriptive, topographique et fonctionnelle. Tome IV, Système nerveux central voies et centres nerveux 2002, Masson, Paris. 15e éd.
47. Ruifrok A.C.C., van der Kogel A.J. The effect of intra spinal cytosine arabinoside on the re-irradiation tolerance of the cervical spinal cord of young and adult rats. Eur J Cancer 1993, 29A:1766-1770.
48. Ryu S., Jin J., Jin R., Rock J., Ajlouni M., Movsas B., et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 2007, 109:628-636.
49. Sahgal A., Larson D.A., Chang E.L. Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 2008, 71:652-665.
50. Sahgal A, Ma L, Gibbs I, Gerszten PC, Ryu S, Soltys S, et al. Spinal Cord Tolerance for Stereotactic Body Radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, 2009 (in press), http://dx.doi.org/10.1016/j.ijrobp.2009.05.023.
51. St Clair W.H., Arnold S.M., Sloan A.E., Regine W.F. Spinal cord and peripheral nerve injury: current management and investigations. Semin Radiat Oncol 2003, 13:322-332.
52. Sauer R., Keilholz L. The central nervous system: clinical aspects in radiopathology of organs and tissues 1991, Springer-Verlag, Berlin, pp. 213-42.
53. Schultheiss T.E., Stephens L.C. Invited review: permanent radiation myelopathy. Br J Radiol 1992, 65:737-753.
54. Schultheiss T.E., Stephens L.C., Maor M.H. Analysis of the histopathology of radiation myelopathy. Int J Radiat Oncol Biol Phys 1988, 14:27-32.
55. Schultheiss T.E. Spinal cord radiation "tolerance": doctrine versus data. Int J Radiat Oncol Biol Phys 1990, 19(1):219-221.
56. Schultheiss T.E. The radiation dose-response of the human spinal cord. Int J Radiat Oncol Biol Phys 2008, 71:1455-1459.
57. Schultheiss T.E., Kun L.E., Ang K.K., Stephens L.C. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995, 31(5):1093-1112.
58. Schultheiss T.E., Schechter G.P., Seltzer S., Chauncey T.R. Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin's lymphoma. Bone Marrow Transplant 2000, 26:1355-1359.
59. Seddon B.M., Cassoni A.M., Galloway M.J., Rees J.H., Whelan J.S. Fatal radiation myelopathy aftr high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: a review of the literature and implications for practice. Clin Oncol 2005, 17:385-390.
60. Harnsberger HR, Osborn AG, McDonald AJ, Ross JS Ed, Spinal cord and cauda equina. In: Diagnostic and Surgical anatomy. Salt Lake City, UT: Lippincott Williams and Wilkins, 2007, III, pp. 10-25.
61. Thames H.D., Ang K.K., Stewart F.A., van der Schueren E. Does incomplete repair explain the apparent failure of the basic LQ model to predict spinal cord and kidney responses to low doses per fraction?. Int J Radiat Biol 1988, 54:13-19.
62. Tofilon P.J., Fike J.R. The radioresponse of the central nervous system: a dynamic process. Radiat. Res 2000, 153:357-370.
63. van der Kogel A. The nervous system: radiology and experimental pathology. Radiopathology of organs and tissues 1991, Springer-Verlag, Berlin, pp. 191-212.
64. van der Schueren E, Landuyt W., Ang K.K., van der Kogel A.J. From 2 Gy to 1 Gy per fraction: sparing effect in rat spinal cord?. Int J Radiat Oncol Biol Phys 1988, 14:297-300.
65. Wong C.S., van der Kogel A.J. Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. Mol Interv 2004, 4:273-284.